Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: interstitial lung disease

Inside Cambodia’s Struggles with Poverty, Dearth of Trained Rheumatologists

Elizabeth Hofheinz, MPH, Med  |  December 18, 2017

It’s one thing for a developing country to lack physicians due to a scarcity of training. It’s quite another for such a vacuum to exist because the physicians were executed. In Cambodia in the 1970s, genocide perpetrated by the Khmer Rouge spared few of the educated class. If they were spared, chances were they lost…

Filed under:ConditionsProfiles Tagged with:CambodiacostsDiagnosisDr. Victoria SeligmandrugEducationgenocideHealth Volunteers OverseasKhmer RougeLupuspatient carephysicianpovertyrheumatologistrheumatologySihanouk Hospital Center of HopeSLETrainingVolunteer

Key Findings in Basic Science This Year Hold Promise for Potential Rheumatology Therapies

Thomas R. Collins  |  December 18, 2017

SAN DIEGO—After sifting through the nitty-gritty of the rheumatic disease literature on basic science, Richard Pope, MD—professor of medicine specializing in rheumatology at Northwestern University Feinberg School of Medicine—underscored several findings he thought stood out from the pack in his Year in Review talk at the 2017 ACR/ARHP Annual Meeting. He reviewed findings from November…

Filed under:ConditionsMeeting ReportsResearch Rheum Tagged with:2017 ACR/ARHP Annual MeetingAC&RAdenosineAmerican College of Rheumatology (ACR)findingsmicemicrogliaNature CommunicationsOsteoarthritisResearchrheumatologistrheumatologysciencestudytherapy

Fellows’ Forum Case Report: Necrotizing Autoimmune Myopathy

Shivani Garg, MD, Suzana Alex John, MD, & Frehiywot Ayele, MD  |  December 18, 2017

Necrotizing autoimmune myopathy (NAM) is a relatively recently discovered subgroup of inflammatory myopathies. NAM is characterized by predominant muscle fiber necrosis and regeneration with little or no inflammation.1 One subgroup of NAM is 3-hydroxy-3-methylglutaryl-CoA reductase antibody (HMGCR Ab)-related immune-mediated necrotizing myopathy (IMNM), which occurs (rarely) after statin exposure, with a rough incidence of two per…

Filed under:Other Rheumatic ConditionsResearch Rheum Tagged with:Autoimmunecase reportClinicalDiagnosisfellowFellowsFellows ForumHMGCR Ab-related IMNMimmune-mediated necrotizing myopathyinflammatory myopathymorbiditymortalitymuscle weaknessmyalgianecrotizingpatient careResearchrespiratoryrheumatologistrheumatologyStatinstatin-associated myopathy

A History of the Science, Treatment of Rheumatologic Illnesses from Gold to Gene Therapy

Simon M. Helfgott, MD  |  December 17, 2017

Mysterious Ways The juxtaposition of the old and the new was readily evident that busy Wednesday morning. My first patient, a 94-year-old gentleman, Hal, arrived with a precise request. His rheumatologist for the past 40 years had just retired, and he was searching for a doctor with expertise in the use of gold sodium aurothioglucose,…

Filed under:ConditionsOpinionResearch RheumRheuminationsSpeak Out Rheum Tagged with:American College of Rheumatology (ACR)American Rheumatism AssociationArthritisautoimmune mediated diseasebioinformaticsC-reactive proteinClinicalcorticosteroid drugsDiagnosisgenomicsHistoryimmune-suppressive therapiesinflammationknowledgemedicalpatient careResearchRheumatic Diseaserheumatologysciencetranslational researchTreatment

2017 in Review: Key Findings in Basic Science Highlighted at the ACR/ARHP Annual Meeting

Thomas R. Collins  |  November 14, 2017

During the ACR/ARHP Annual Meeting, Richard Pope, MD, highlighted some of the top scientific literature on rheumatic disease from 2017. The review session discussed research on the effects of microglia on the central nervous system of SLE patients, the role of adenosine in osteoarthritis and more…

Filed under:Meeting Reports Tagged with:2017 ACR/ARHP Annual MeetingACR/ARHP Annual MeetingAdenosinecentral nervous systemIL-17osteoarthritis (OA)Sclerodermasystemic lupus erythematosus (SLE)

Systemic Sclerosis Mortality Rate May Be Underestimated

Kurt Ullman  |  November 6, 2017

Systemic sclerosis (SSc) is a disease characterized by immunologic abnormalities, microvascular involvement and tissue fibrosis. In previous studies, 10-year survival rates ranged from 50–84%. However, there are concerns that these studies, using prevalent cohorts, are underestimating mortality. “While the prognosis of many rheumatic diseases has improved with the availability of more effective and targeted therapies,…

Filed under:ConditionsOther Rheumatic ConditionsResearch Rheum Tagged with:heart-lungmortalityorgan damagepatient careraterenal complicationResearchrheumatologistrheumatologyriskSclerodermastudysurvivalSystemic sclerosisTreatment

Rheumatologists Find Nailfold Capillaroscopy an Increasingly Useful Diagnostic Tool

Ruth Jessen Hickman, MD  |  October 18, 2017

Interest in viewing the nail capillaries dates to the late 17th century. Later research by Maurice Raynaud and others in the late 19th and early 20th century first established a direct link between the nailfold capillaries and certain medical conditions. Although underutilized in the past, with the advent of modern digital equipment and the validation…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:Clinicaldiagnostic toolnailfold capillaroscopyoffice visitpatient carePractice ManagementRaynaud’s phenomenonrheumatologistrheumatologysymptomSystemic sclerosis

Research Links Macrophages with Pathogenesis of Inflammation, Fibrosis

Thomas R. Collins  |  October 17, 2017

MADRID—Research into pharmacodynamic biomarkers has shown that macrophages may have an important role in the pathogenesis of several diseases, including systemic sclerosis, an expert said at the 2017 Annual European Congress on Rheumatology (EULAR). The findings were discussed in a session that also covered how an understanding of M1 macrophages’ role in fibrosis has evolved…

Filed under:ConditionsMeeting ReportsOther Rheumatic ConditionsResearch Rheum Tagged with:BiomarkersEULARfibrosisinflammationmacrophagemeeting reportsPathogenesispharmacodynamicpredictResearchRheumatic Diseaserheumatologyskin diseaseskin scoreSystemic sclerosis

Fellows’ Forum Case Report: Progressive Multifocal Leukoencephalopathy and RA

Eugene Jalbert, DO, MBA, Priyanka Murali, DO, Rakhee Shah, DO, Robert DiGiovanni, DO, FACOI, FACR, & Rubaiya Mallay, DO, FACOI, FACR  |  September 18, 2017

Rheumatoid arthritis (RA) is a systemic autoimmune disease associated with erosive destruction of diarthrodial joints. Patients who are seropositive are more prone to developing extra-articular manifestations, such as rheumatoid lung, rheumatoid nodules and others. With the development of disease-modifying anti-rheumatic drugs (DMARDs), the incidence and severity of these extra-articular manifestations has declined. Below, we describe…

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:ClinicalDiagnosisfellowFellowsFellows Forumoutcomeprogressive multifocal leukoencephalopathyResearchRheumatoid arthritisrheumatologistrheumatology

Autoantibodies in Autoimmune Myopathy

Autoantibodies in Autoimmune Myopathy

Ruth Jessen Hickman, MD  |  September 18, 2017

In recent years, scientists and clinicians have learned a great deal about autoantibodies occurring in idiopathic inflammatory myopathies (IIMs). These new discoveries have reshaped our understanding of distinct clinical pheno­types in IIMs. Scientists continue to learn more about how these auto­antibodies shape pathophysiology, diagnosis, disease monitoring, prognosis and optimum treatment. Moving forward, these autoantibodies will…

Filed under:ConditionsMyositisOther Rheumatic ConditionsResearch Rheum Tagged with:autoantibodiesAutoimmune diseaseClassificationconnective tissue diseasedermatomyositisDiagnosisidiopathic inflammatory myopathiesmyositispatient carepolymyositisprognosisResearchrheumatologistrheumatologySystemic sclerosisTestTreatment

  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 26
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences